Novel Mucoadhesive Wafers for Treating Local Vaginal Infections

Current vaginal formulations, such as gels and pessaries, have limitations, including poor retention. Therefore, the use of mucoadhesive formulations that adhere to the vaginal wall would allow prolonged retention and controlled drug release while reducing the required dose and the potential toxicit...

Full description

Bibliographic Details
Main Authors: Ahmed Alzainy, Joshua Boateng
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/10/12/3036
_version_ 1797461364016414720
author Ahmed Alzainy
Joshua Boateng
author_facet Ahmed Alzainy
Joshua Boateng
author_sort Ahmed Alzainy
collection DOAJ
description Current vaginal formulations, such as gels and pessaries, have limitations, including poor retention. Therefore, the use of mucoadhesive formulations that adhere to the vaginal wall would allow prolonged retention and controlled drug release while reducing the required dose and the potential toxicity associated with high drug loading. The aim of the current research was to develop, characterize, and optimize freeze-dried wafers loaded with metronidazole (MTz) to treat vaginal bacterial infections. Blank (BLK) composite wafers comprising carrageenan (CARR) and sodium alginate (SA) were initially formulated; however, due to poor physico-chemical properties, Carbopol (CARB), hydroxypropylmethylcellulose (HPMC), and polyethylene glycol 200 (PEG) were included. The MTz-loaded formulations were obtained by loading optimized composite CARB:CARR- or CARB:SA-based gels (modified with HPMC and/or PEG) with 0.75% of MTz prior to freeze-drying. The physico-chemical properties were investigated using texture analysis (resistance to compressive deformation and adhesion), scanning electron microscopy (SEM), X-ray diffractometry (XRD), and attenuated total reflectance Fourier-transform infrared (ATR-FTIR) spectroscopy. Functional properties were investigated by examining the swelling, porosity, drug release, and in vitro antimicrobial activity using <i>E. coli</i> as a model infection-causative agent. The results showed that HPMC and PEG generally improved the wafer’s appearance, with smoother surfaces for easy insertion. From the physico-chemical characterization studies, only two composite wafers prepared from 8% CARB:SA 1:4 and 8% CARB:SA 1:9 gels were deemed optimal and loaded with MTz. Both formulations showed sustained drug release and achieved almost 100% cumulative release within 72 h in simulated vaginal fluid. The data obtained from the drug dissolution (release) experiments were fitted to various mathematical equations and showed the highest correlation coefficient with the Higuchi equation, suggesting a drug release based on diffusion from a swollen matrix; this was confirmed by the Korsmeyer–Peppas equation. The released MTz inhibited the growth of the <i>E</i>. <i>coli</i> used as a model bacterial organism.
first_indexed 2024-03-09T17:18:22Z
format Article
id doaj.art-8dcb43d57d1d4431a06c96aa1a762f8a
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-09T17:18:22Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-8dcb43d57d1d4431a06c96aa1a762f8a2023-11-24T13:25:35ZengMDPI AGBiomedicines2227-90592022-11-011012303610.3390/biomedicines10123036Novel Mucoadhesive Wafers for Treating Local Vaginal InfectionsAhmed Alzainy0Joshua Boateng1School of Science, Faculty of Engineering and Science, University of Greenwich at Medway, Central Avenue, Chatham Maritime, Chatham, City of Canterbury ME4 4TB, UKSchool of Science, Faculty of Engineering and Science, University of Greenwich at Medway, Central Avenue, Chatham Maritime, Chatham, City of Canterbury ME4 4TB, UKCurrent vaginal formulations, such as gels and pessaries, have limitations, including poor retention. Therefore, the use of mucoadhesive formulations that adhere to the vaginal wall would allow prolonged retention and controlled drug release while reducing the required dose and the potential toxicity associated with high drug loading. The aim of the current research was to develop, characterize, and optimize freeze-dried wafers loaded with metronidazole (MTz) to treat vaginal bacterial infections. Blank (BLK) composite wafers comprising carrageenan (CARR) and sodium alginate (SA) were initially formulated; however, due to poor physico-chemical properties, Carbopol (CARB), hydroxypropylmethylcellulose (HPMC), and polyethylene glycol 200 (PEG) were included. The MTz-loaded formulations were obtained by loading optimized composite CARB:CARR- or CARB:SA-based gels (modified with HPMC and/or PEG) with 0.75% of MTz prior to freeze-drying. The physico-chemical properties were investigated using texture analysis (resistance to compressive deformation and adhesion), scanning electron microscopy (SEM), X-ray diffractometry (XRD), and attenuated total reflectance Fourier-transform infrared (ATR-FTIR) spectroscopy. Functional properties were investigated by examining the swelling, porosity, drug release, and in vitro antimicrobial activity using <i>E. coli</i> as a model infection-causative agent. The results showed that HPMC and PEG generally improved the wafer’s appearance, with smoother surfaces for easy insertion. From the physico-chemical characterization studies, only two composite wafers prepared from 8% CARB:SA 1:4 and 8% CARB:SA 1:9 gels were deemed optimal and loaded with MTz. Both formulations showed sustained drug release and achieved almost 100% cumulative release within 72 h in simulated vaginal fluid. The data obtained from the drug dissolution (release) experiments were fitted to various mathematical equations and showed the highest correlation coefficient with the Higuchi equation, suggesting a drug release based on diffusion from a swollen matrix; this was confirmed by the Korsmeyer–Peppas equation. The released MTz inhibited the growth of the <i>E</i>. <i>coli</i> used as a model bacterial organism.https://www.mdpi.com/2227-9059/10/12/3036Carbopolcarrageenanmetronidazolemucoadhesionsodium alginatevaginal infection
spellingShingle Ahmed Alzainy
Joshua Boateng
Novel Mucoadhesive Wafers for Treating Local Vaginal Infections
Biomedicines
Carbopol
carrageenan
metronidazole
mucoadhesion
sodium alginate
vaginal infection
title Novel Mucoadhesive Wafers for Treating Local Vaginal Infections
title_full Novel Mucoadhesive Wafers for Treating Local Vaginal Infections
title_fullStr Novel Mucoadhesive Wafers for Treating Local Vaginal Infections
title_full_unstemmed Novel Mucoadhesive Wafers for Treating Local Vaginal Infections
title_short Novel Mucoadhesive Wafers for Treating Local Vaginal Infections
title_sort novel mucoadhesive wafers for treating local vaginal infections
topic Carbopol
carrageenan
metronidazole
mucoadhesion
sodium alginate
vaginal infection
url https://www.mdpi.com/2227-9059/10/12/3036
work_keys_str_mv AT ahmedalzainy novelmucoadhesivewafersfortreatinglocalvaginalinfections
AT joshuaboateng novelmucoadhesivewafersfortreatinglocalvaginalinfections